Try a new search

Format these results:

Searched for:

person:goldbi05 or hodaks01 or katzg01 or bergmm01 or probsj01 or agrawn01 or alemaj01 or aravid01 or bahtig01 or baldwc02 or bellop01 or blaseb01 or blumm01 or bojadt01 or cadend01 or chauds05 or ac853 or constt03 or convia01 or eytans01 or filopm01 or foos02 or gaged01 or mbg287 or gmm251 or goldel03 or goulla01 or tiwara03 or greenl01 or harria04 or hurstl01 or jacknc01 or jacobr14 or kk1468 or kinkhs01 or daleyk03 or kudejm01 or vl296 or polono01 or levyb01 or manesa01 or muelle01 or newmac01 or newmal02 or ajp242 or ncp234 or peckv01 or ramasr02 or schmia1000 or samueh01

active:yes

exclude-minors:true

Total Results:

1641


PTH stimulation of Rankl transcription is regulated by SIK2 and 3 and mediated by CRTC2 and 3 through action of protein phosphatases 1, 2, 4, and 5

Mosca, Michael J; He, Zhiming; Selvamurugan, Nagarajan; Joseph, Jobin; Petrosky, Whitney; Le Henaff, Carole; Partridge, Nicola C
Osteoporosis is characterized by a decrease in the density and quality of bone tissue and is associated with substantial morbidity/mortality. Homeostatic processes that form new and remove old/damaged bone are dysregulated, with resultant net bone resorption. Parathyroid hormone (PTH) is a key regulator of this homeostasis and along with its analogs has been used to treat osteoporosis, however its use is limited to an "anabolic window". PTH stimulates both formation and resorption, the latter largely due to increased receptor activator of nuclear factor kappa-β ligand (RANKL). Our laboratory has found a cascade of messengers, Salt-inducible kinases (SIKs) and protein phosphatases (PPs) regulate nuclear translocation of CREB-regulated transcriptional coactivators (CRTCs) but the individual and/or combined contributions of these factors has not yet been established in osteoblasts. In this study, we reveal precise mechanisms involved in CRTC1/2/3 nuclear translocation and delineate their roles as co-activators of Tnfsf11 (RANKL gene name) transcription throughout osteoblast differentiation using a primary mouse calvarial osteoblast model. By performing a series of siRNA knockdowns of CRTC1/2/3, SIK1/2/3, and PP1/2/3/4/5/6/7 we determined the regulation of CRTCs upon PTH-stimulation via qPCR, quantitative immunofluorescence, Western blotting, and co-immunoprecipitation. CRTC2 is determined to be the primary co-activator of Tnfsf11 transcription with SIK2/3 inhibition upon PTH-stimulation making CRTC2 available for nuclear translocation by PP1/2/4/5 action. Understanding the mechanisms involved in this cascade may reveal novel targets in the treatment of osteoporosis and allow researchers a new line of approach for drug design that could overcome the "anabolic window" limiting current PTH-derived treatments.
PMID: 40609791
ISSN: 1083-351x
CID: 5888362

Baseline Characteristics of Weight-Loss Success in a Personalized Nutrition Intervention: A Secondary Analysis

Popp, Collin J; Wang, Chan; Berube, Lauren; Curran, Margaret; Hu, Lu; Pompeii, Mary Lou; Barua, Souptik; Li, Huilin; St-Jules, David E; Schoenthaler, Antoinette; Segal, Eran; Bergman, Michael; Sevick, Mary Ann
PMID: 40647283
ISSN: 2072-6643
CID: 5891412

Pituitary incidentaloma: a Pituitary Society international consensus guideline statement

Fleseriu, Maria; Gurnell, Mark; McCormack, Ann; Fukuoka, Hidenori; Glezer, Andrea; Langlois, Fabienne; Schwartz, Theodore H; Greenman, Yona; Agrawal, Nidhi; Akirov, Amit; Bancos, Irina; Capatina, Cristina; Castinetti, Frederic; Catalino, Michael; Christ-Crain, Mirjam; Das, Liza; Drincic, Andjela; Freda, Pamela U; Gadelha, Monica R; Giustina, Andrea; Hanzu, Felicia; Ho, Ken K Y; Isand, Kristina; Mallea-Gil, Susana; Mamelak, Adam N; Marcus, Hani J; Uygur, Meliha Melin; Molitch, Mark; Nachtigall, Lisa B; Nowak, Elisabeth; Pereira, Alberto M; Pineyro, Maria M; Shafiq, Ismat; Syro, Luis; Takahashi, Yutaka; Varlamov, Elena V; Vila, Greisa; Zada, Gabriel; Karavitaki, Niki; Melmed, Shlomo; ,
This Pituitary Society Consensus article presents an evidence-based consensus on the management of pituitary incidentaloma, defined as an unexpected sellar or parasellar finding incidentally discovered on an imaging study that was not performed for a clinically suspected pituitary lesion. Recommendations are offered for when endocrinology, neurosurgery and ophthalmology consultation, dedicated pituitary imaging, pituitary hormone testing and visual assessment are warranted for macroadenomas, microadenomas, cystic lesions and empty sella, as well as when surgical resection is indicated for incidental pituitary adenomas and cystic sellar lesions. Special considerations in patients with multiple endocrine neoplasia type 1, children and adolescents, older people, and pregnant women are addressed. The Consensus workshop concluded that diagnostic and management approaches should be individualized to the specific clinical context of an incidentally discovered pituitary lesion. Consultation with a multidisciplinary pituitary tumour centre of excellence should be considered in the presence of new or deteriorating lesion-specific signs or symptoms, particularly when surgical or other adjuvant interventions are being considered and when there is uncertainty about the most appropriate subsequent management.
PMID: 40555795
ISSN: 1759-5037
CID: 5886922

BMI-Specific Nutritional Education Priorities for Weight Management in Osteoarthritis

Buck, Ashley N; Gross, Danae C; Kim, Jieun Jenna; Rauff, Erica L; Dinallo, Jennifer M; Abbate, Lauren M; Schwartz, Todd A; Beresic, Nicholas J; Newman, Connie B; Shultz, Sarah P
PMID: 40647161
ISSN: 2072-6643
CID: 5891392

Enhanced detection of primary aldosteronism in hypertensive patients with obstructive sleep apnea using a novel diagnostic algorithm

Shah, Shruti N; Wright, Kyla; Suh, Insoo; Mahmoudi, Mandana; Agrawal, Nidhi
PURPOSE/OBJECTIVE:Primary aldosteronism (PA) is an underdiagnosed cause of secondary hypertension with significant health consequences. Expanding screening criteria may improve case detection and reduce the number of untreated patients. METHODS:We assessed PA screening rates in a cohort of 457 adults with comorbid obstructive sleep apnea (OSA) and hypertension (HTN). PA screening in a subset of the cohort (n = 97, 21%) was conducted using serum aldosterone, aldosterone-to-plasma renin activity ratio (ARR), and plasma renin activity (PRA). Screening results were compared between the 2016 Endocrine Society guidelines (serum aldosterone and ARR) and the Vaidya & Carey algorithm (serum aldosterone and PRA). RESULTS:The screened patients were predominantly male (mean age 58.6 years), with common comorbidities including hyperlipidemia (80%) and diabetes mellitus (31%). PA positivity rates differed significantly between screening criteria: 7% tested positive using Endocrine Society guidelines, while 33% screened positive using the Vaidya & Carey algorithm. Notably, 26% of patients with negative screens by Endocrine Society criteria were reclassified as positive, and 11 previously indeterminate cases were classified as negative due to absent renin suppression. Using the Vaidya & Carey algorithm with a stricter PRA suppression threshold, 25% of patients screened positive. CONCLUSION/CONCLUSIONS:The Vaidya & Carey algorithm may be an important tool in increasing detection of previously unidentified cases and clarifying the diagnosis of cases that were previously deemed indeterminate. Given the morbidity of untreated PA, more robust screening approaches are warranted. Prospective studies are needed to validate these findings across diverse populations.
PMID: 40526320
ISSN: 1559-0100
CID: 5870362

Variations in weight loss and glycemic outcomes after sleeve gastrectomy by race and ethnicity

Vanegas, Sally M; Curado, Silvia; Zhou, Boyan; Illenberger, Nicholas; Merriwether, Ericka N; Armijos, Evelyn; Schmidt, Ann Marie; Ren-Fielding, Christine; Parikh, Manish; Elbel, Brian; Alemán, José O; Jay, Melanie
OBJECTIVE:This study examined racial and ethnic differences in percent total weight loss (%TWL) and glycemic improvement following sleeve gastrectomy (SG) and explored the role of socioeconomic and psychosocial factors in postsurgical outcomes. METHODS:This longitudinal study included patients who underwent SG between 2017 and 2020, with follow-up visits over 24 months. RESULTS:Non-Hispanic Black (NHB) participants had lower %TWL at 3, 12, and 24 months compared with Hispanic (H) and non-Hispanic White (NHW) participants. Fat mass index was initially lower in NHB, with smaller reductions over time and significant group differences persisting at 24 months. NHB participants had higher baseline fat-free mass index values; by 24 months, fat-free mass index values were lower in H participants. Hemoglobin A1c decreased across all groups but remained consistently higher in NHB and H compared with NHW at 24 months. NHB participants reported higher perceived discrimination, sleep disturbance, and perceived stress than H and NHW participants at all time points. Employment status predicted %TWL at 12 months. There was a significant interaction between race and ethnicity and employment status observed at 12 and 24 months, suggesting that employment-related disparities could impact surgical outcomes. CONCLUSIONS:NHB participants experienced less favorable outcomes following SG, emphasizing the need for tailored interventions addressing socioeconomic and psychosocial disparities.
PMID: 40524421
ISSN: 1930-739x
CID: 5870822

Weight loss is associated with improved daytime time in range in adults with prediabetes and non-insulin-treated type 2 diabetes undergoing dietary intervention

Barua, Souptik; Upadhyay, Dhairya; Berube, Lauren T; Popp, Collin J; Curran, Margaret; Pompeii, Mary Lou; Hu, Lu; Aleman, Jose O; Bergman, Michael; Sevick, Mary Ann
AIMS/OBJECTIVE:To characterize changes in continuous glucose monitoring (CGM)-derived time in tight range (TIR) measures in individuals with prediabetes or non-insulin-treated type 2 diabetes undergoing dietary weight loss intervention and to quantify the association between weight loss and TIR improvement. METHODS:) were analysed. The association between weight change and TIR change adjusted for demographic and clinical covariates was computed using linear regression. RESULTS:. There were no associations between weight loss and change in any overnight TIR measure. CONCLUSION/CONCLUSIONS:in individuals with prediabetes and non-insulin-treated type 2 diabetes undergoing dietary intervention. The daytime time in tight range measures can complement traditional markers like HbA1c, offering a more comprehensive view of glycaemic variations during dietary weight loss programmes for individuals with prediabetes and type 2 diabetes not on insulin.
PMID: 40460001
ISSN: 1464-5491
CID: 5862262

Effect of complete, lifelong ANGPTL3 deficiency on triglyceride-rich lipoprotein kinetics

Fappi, Alan; Patterson, Bruce W; Burks, Kendal H; Davidson, Nicholas O; Vaisar, Tomas; Kanter, Jenny E; Bornfeldt, Karin E; Fisher, Edward A; Goldberg, Ira J; Stitziel, Nathan O; Mittendorfer, Bettina
Angiopoietin-like 3 (ANGPTL3) inhibits lipases that hydrolyze triglycerides (TGs) in TG-rich lipoproteins (TRLs). We evaluated TRL-TGs, TRL particle (apolipoprotein B), palmitate, and glucose kinetics during a mixed-meal test that included intravenous and oral tracer administrations in people with extremely rare compound heterozygous ANGTPL3 loss-of-function mutations (ANGPTL3-/- group, n = 3) and matched control participants (n = 7). Multi-organ (liver, muscle, and adipose tissue) insulin sensitivity was evaluated with a two-step hyperinsulinemic-euglycemic clamp procedure and glucose and palmitate tracer infusions. We find that plasma TG and TRL particle concentrations are more than 10-fold lower in the ANGPTL3-/- than in the control group due to both markedly reduced liver-derived TRL particle and TG secretion rates combined with increased plasma clearance of both liver- and gut-derived TRLs. Palmitate and glucose kinetics during the meal test are not different between the groups. We conclude that the biological function of ANGPTL3 reaches beyond inhibiting intravascular lipase activity.
PMID: 40446802
ISSN: 2666-3791
CID: 5854562

Negative cooperativity regulates ligand activation of DIAPH1 and other diaphanous related formins

Theophall, G G; Premo, A; Reverdatto, S; Omojowolo, E; Nazarian, P; Burz, D S; Ramasamy, R; Schmidt, A M; Shekhtman, A
DIAPH1 is a member of the family of Diaphanous Related Formins (DRFs) implicated in cell migration and cytokinesis. DRFs are maintained in an autoinhibited state by the intramolecular association between diaphanous inhibitory (DID) and diaphanous autoregulatory (DAD) domains. Actin polymerization requires the binding of activated RhoA to the GTPase binding domain (GBD) of DIAPH1 and the dissociation of DAD. In the presence of excess RhoA, actin polymerization is only partially activated. Using monomeric domain constructs of DIAPH1, the sequential binding affinities of RhoA and DAD to GBD-DID were characterized. Binding of RhoA and DAD were negatively cooperative requiring a 100-fold greater concentration of DAD to achieve saturation when RhoA binding site was occupied. The unimolecular architecture of full length DIAPH1 establishes an effective concentration of DAD in the micromolar range, which is 100-fold larger than the intrinsic affinity of DAD for DID. The effective concentration is large enough to maintain DIAPH1 autoinhibition, yet small enough to permit partial activation of DIAPH1 after RhoA binding. By exploiting negative cooperativity, DIAPH1 maintains a reserve of inactivated molecules enabling gradual responses to cellular processes that require prolonged and sustained regulation. The proposed mechanism is extended to other DIAPH1 activating ligands and broadly applicable to all DRFs.
PMCID:12095592
PMID: 40399622
ISSN: 2399-3642
CID: 5853212

DNA methylation profiling of pituitary neuroendocrine tumors identifies distinct clinical and pathological subtypes based on epigenetic differentiation

Belakhoua, Sarra; Vasudevaraja, Varshini; Schroff, Chanel; Galbraith, Kristyn; Movahed-Ezazi, Misha; Serrano, Jonathan; Yang, Yiying; Orringer, Daniel; Golfinos, John G; Sen, Chandra; Pacione, Donato; Agrawal, Nidhi; Snuderl, Matija
BACKGROUND:Pituitary neuroendocrine tumors (PitNETs) are the most common intracranial neuroendocrine tumors. PitNETs can be challenging to classify, and current recommendations include a large immunohistochemical panel to differentiate among 14 WHO-recognized categories. METHODS:In this study, we analyzed clinical, immunohistochemical and DNA methylation data of 118 PitNETs to develop a clinico-molecular approach to classifying PitNETs and identify epigenetic classes. RESULTS:CNS DNA methylation classifier has an excellent performance in recognizing PitNETs and distinguishing the three lineages when the calibrated score is ≥0.3. Unsupervised DNA methylation analysis separated PitNETs into two major clusters. The first was composed of silent gonadotrophs, which form a biologically distinct group of PitNETs characterized by clinical silencing, weak hormonal expression on immunohistochemistry, and simple copy number profile. The second major cluster was composed of corticotrophs and Pit1 lineage PitNETs, which could be further classified using DNA methylation into distinct subclusters that corresponded to clinically functioning and silent tumors and are consistent with transcription factor expression. Analysis of promoter methylation patterns correlated with lineage for corticotrophs and Pit1 lineage subtypes. However, the gonadotrophic genes did not show a distinct promoter methylation pattern in gonadotroph tumors compared to other lineages. Promoter of the NR5A1 gene, which encodes SF1, was hypermethylated across all PitNETs clinical and molecular subtypes including gonadotrophs with strong SF1 protein expression indicating alternative epigenetic regulation. CONCLUSION/CONCLUSIONS:Our findings suggest that classification of PitNETs may benefit from DNA methylation for clinicopathological stratification.
PMID: 40295206
ISSN: 1523-5866
CID: 5833282